Skip to Main Content

Paper Details

Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer.
Cancer Res
79
2019
Author NameAffiliation
Adam SharpInstitute of Cancer Research
Adam SharpRoyal Marsden Hospital
Wei YuanInstitute of Cancer Research
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonFred Hutchinson Cancer Research Center
Felix Y FengHelen Diller Family Comprehensive Cancer Center, University of California San Francisco
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Johann S de BonoInstitute of Cancer Research
Johann S de BonoRoyal Marsden Hospital
Colm MorrisseyUniversity of Washington
Matthew B RettigDavid Geffen School of Medicine at university of california los angeles
Matthew B RettigVA Greater Los Angeles Healthcare System
  • 1 - 13

Datasets

Release 1.2